SIX2 and nasopharyngeal carcinoma: In support of this notion, we found that preventing NPC differentiation by DAPT, a γ-secretase inhibitor that inhibits Notch signaling pathway, was effective to maintain and expand Six2+-NPC in P1 aggregates by up to 65-fold.